To read more about the VALOR-HCM study, please visit [ Ссылка ]

Findings from a Cleveland Clinic-led clinical trial, the VALOR-HCM study, showed that the use of mavacamten in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.

To learn more about Dr. Milind Desai, please visit [ Ссылка ]

If you liked the video hit like and subscribe for more!
#clevelandclinic #consultqd #valorhcm

свернуть